BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Audia S, Bonnotte B. Emerging Therapies in Immune Thrombocytopenia. J Clin Med 2021;10:1004. [PMID: 33801294 DOI: 10.3390/jcm10051004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Akyol Ş, Tüfekçi Ö, Yılmaz Ş, Ören H. Evaluation of paediatric immune thrombocytopenia patients with clinical and laboratory findings: emphasizing the role of monocytosis. Blood Coagul Fibrinolysis 2022. [PMID: 35834725 DOI: 10.1097/MBC.0000000000001146] [Reference Citation Analysis]
2 Nunez-Castilla J, Stebliankin V, Baral P, Balbin CA, Sobhan M, Cickovski T, Mondal AM, Narasimhan G, Chapagain P, Mathee K, Siltberg-Liberles J. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins. Viruses 2022;14:1415. [PMID: 35891400 DOI: 10.3390/v14071415] [Reference Citation Analysis]
3 Gómez-Almaguer D, Rojas-Guerrero EA, Gómez-De León A, Colunga-Pedraza PR, Jaime-Pérez JC. Alternatives for managing patients with newly diagnosed immune thrombocytopenia: a narrative review. Expert Rev Hematol 2022. [PMID: 35615916 DOI: 10.1080/17474086.2022.2082936] [Reference Citation Analysis]
4 Roşu VE, Spoială E, Roşu TS, Ivanov A, Mocanu A, Munteanu A, Lupu VV, Miron I, Gavrilovici C. The Use of Clinical Scores in the Management of Immune Thrombocytopenic Purpura in Children. Front Pediatr 2022;10:870064. [DOI: 10.3389/fped.2022.870064] [Reference Citation Analysis]
5 Wang L, Wang DD, Jiao RY, Liu CX, Hou YQ, Qin H, He HJ. The Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients. Acta Haematol 2022. [PMID: 35405676 DOI: 10.1159/000524535] [Reference Citation Analysis]
6 Vianelli N, Auteri G, Buccisano F, Carrai V, Baldacci E, Clissa C, Bartoletti D, Giuffrida G, Magro D, Rivolti E, Esposito D, Podda GM, Palandri F. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives. Ann Hematol 2022. [PMID: 35201417 DOI: 10.1007/s00277-022-04786-y] [Reference Citation Analysis]
7 Sun S, Urbanus RT, ten Cate H, de Groot PG, de Laat B, Heemskerk JWM, Roest M. Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia. Cells 2021;10:3386. [DOI: 10.3390/cells10123386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Nelson VS, Jolink AC, Amini SN, Zwaginga JJ, Netelenbos T, Semple JW, Porcelijn L, de Haas M, Schipperus MR, Kapur R. Platelets in ITP: Victims in Charge of Their Own Fate? Cells 2021;10:3235. [PMID: 34831457 DOI: 10.3390/cells10113235] [Reference Citation Analysis]
9 Audia S, Mahévas M, Nivet M, Ouandji S, Ciudad M, Bonnotte B. Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments. Hemasphere 2021;5:e574. [PMID: 34095758 DOI: 10.1097/HS9.0000000000000574] [Reference Citation Analysis]